You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 5, May 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Natural Killer Cell Response to Regional Lymph Node Metastases

Stimson P. Schantz, MD; Louis Poisson, MS

Arch Otolaryngol Head Neck Surg. 1986;112(5):545-551.


Abstract

• A determination of natural killer cell activity was performed in 67 individuals with advanced head and neck cancer. The mean activity of 28 patients clinically staged T3 NO or T4 NO was 81 ± 11 lytic units (LU), significantly higher than 39 patients with palpable lymph node metastases (54 ± 5 LU). Assessing patients by extent of nodal disease revealed that activity actually increased, though not significantly, with progressive N-staging. A major determinate of increased natural killer cell cytotoxicity in patients with lymph node metastases was extranodal cancer within the neck. The mean activity of nine patients whose tumor was fixed to underlying structures or adherent to skin was 87 ± 15 LU, significantly higher than the 45 ± 4 LU mean value of the remaining patients with clinically determined regional nodal disease. The potential clinical implications of these findings are discussed.

(Arch Otolaryngol Head Neck Surg 1986;112:545-551)



Author Affiliations

From the Department of Head and Neck Surgery, M. D. Anderson Hospital and Tumor Institute, Houston.


Footnotes

Accepted for publication Sept 6, 1985.

Read before the fifth joint meeting of the American Society for Head and Neck Surgeons, Dorado, Puerto Rico, May 5, 1985.

Reprint requests to Department of Head and Neck Surgery, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Ave, Houston, TX 77030 (Dr Schantz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phospholipid Metabolite Expression by Head and Neck Squamous Cell Carcinoma
Mann et al.
Arch Otolaryngol Head Neck Surg 1994;120:763-769.
ABSTRACT  

Multimodality Therapy and Distant Metastases: The Impact of Natural Killer Cell Activity
Schantz and Goepfert
Arch Otolaryngol Head Neck Surg 1987;113:1207-1213.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.